M.D. ANDERSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Proton Beam Therapy for Chordoma Patients

Phase 2

Active, not recruiting

Conditions: Chordoma

Interventions: Radiation: Proton Beam Therapy
Radiation: Photon Beam Therapy

First Posted Date: 2007-07-04

Last Posted Date: 2024-10-16

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 19

Registration Number: NCT00496119

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Prospective Measurement of Post-Treatment Lymphedema

Completed

Conditions: Melanoma

Interventions: Behavioral: Questionnaire

First Posted Date: 2007-07-03

Last Posted Date: 2016-11-25

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 350

Registration Number: NCT00495950

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor

Phase 1

Completed

Conditions: Solid Tumors

Interventions: Drug: Sorafenib
Drug: Sunitinib
Drug: Erlotinib
Drug: Lapatinib
Drug: Dasatinib
Drug: Lenalidomide
Drug: Valproic Acid

First Posted Date: 2007-07-03

Last Posted Date: 2012-10-18

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 204

Registration Number: NCT00495872

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Study of Insulin Resistance and Endometrial Cancer in Harris County, Texas

Completed

Conditions: Endometrial Cancer

Interventions: Behavioral: Questionnaire

First Posted Date: 2007-07-03

Last Posted Date: 2014-05-21

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 147

Registration Number: NCT00495235

Locations: 🇺🇸
The Methodist Hospital, Houston, Texas, United States
🇺🇸
Ben Taub Hospital, Houston, Texas, United States
🇺🇸
Gynecologic Oncology of Houston, Houston, Texas, United States

and more 5 locations

Smoking Cessation for Depressed Smokers

Phase 1

Active, not recruiting

Conditions: Smoking
Depression

Interventions: Behavioral: Smoking Cessation Treatment
Drug: Nicotine Replacement Therapy
Behavioral: CBASP

First Posted Date: 2007-07-02

Last Posted Date: 2024-10-23

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 91

Registration Number: NCT00494728

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Effects of Rocking on Postoperative Ileus Duration Study

Early Phase 1

Completed

Conditions: Abdominal Cancer

Interventions: Other: Rocking Chair Intervention

First Posted Date: 2007-07-02

Last Posted Date: 2012-08-07

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 66

Registration Number: NCT00494806

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Concurrent Proton and Chemotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Drug: Carboplatin
Radiation: Proton Radiotherapy
Drug: Paclitaxel

First Posted Date: 2007-07-02

Last Posted Date: 2019-02-06

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 84

Registration Number: NCT00495170

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Proton Radiotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC)

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Radiation: Proton Radiotherapy

First Posted Date: 2007-07-02

Last Posted Date: 2019-01-14

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 38

Registration Number: NCT00495040

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Pre-Surgical Qigong Therapy for Women With Breast Cancer

Completed

Conditions: Breast Cancer

Interventions: Other: Qigong

First Posted Date: 2007-07-02

Last Posted Date: 2018-08-15

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 7

Registration Number: NCT00495209

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Sorafenib in Combination With Carboplatin and Paclitaxel in Treating Participants With Metastatic or Recurrent Head and Neck Squamous Cell Cancer

Phase 2

Active, not recruiting

Conditions: Metastatic Head and Neck Squamous Cell Carcinoma
Metastatic Squamous Cell Carcinoma of the Larynx
Metastatic Squamous Cell Carcinoma of the Oral Cavity
Metastatic Squamous Cell Carcinoma of the Oropharynx
Recurrent Oropharyngeal Squamous Cell Carcinoma
Metastatic Squamous Cell Carcinoma of the Hypopharynx
Recurrent Head and Neck Squamous Cell Carcinoma
Recurrent Hypopharyngeal Squamous Cell Carcinoma
Recurrent Laryngeal Squamous Cell Carcinoma
Recurrent Oral Cavity Squamous Cell Carcinoma

Interventions: Drug: Carboplatin
Drug: Paclitaxel
Drug: Sorafenib

First Posted Date: 2007-06-29

Last Posted Date: 2024-12-05

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 48

Registration Number: NCT00494182

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

Home Terms & Conditions Privacy Policy